Mid Continent Capital’s Bristol-Myers Squibb BMY Stock Holding History

Mid Continent Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$452K	Hold	7,642	–	–	0.03%	210
2015 Q2	$509K	Sell	7,642 -264	-3%	-$17.4K	0.03%	227
2015 Q1	$510K	Sell	7,906 -350	-4%	-$21.9K	0.03%	230
2014 Q4	$487K	Hold	8,256	–	–	0.03%	223
2014 Q3	$422K	Hold	8,256	–	–	0.02%	237
2014 Q2	$400K	Hold	8,256	–	–	0.02%	243
2014 Q1	$428K	Hold	8,256	–	–	0.03%	231
2013 Q4	$439K	Hold	8,256	–	–	0.03%	232
2013 Q3	$382K	Hold	8,256	–	–	0.03%	233
2013 Q2	$369K	Buy	+8,256	New	+$358K	0.03%	227

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mid Continent Capital's BMY Position: Q3 2015 in Review

Mid Continent Capital held its Bristol-Myers Squibb (BMY) position steady in Q3 2015 at 7,642 shares worth $452K. The position accounts for 0.03% of the portfolio, ranked #210.

Mid Continent Capital first reported a position in BMY in Q2 2013 and has held it in 10 quarters since. The position peaked at $510K in Q1 2015. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

Mid Continent Capital held 7,642 shares of Bristol-Myers Squibb worth $452K as of Q3 2015.
Mid Continent Capital left its Bristol-Myers Squibb share count unchanged in Q3 2015.
Bristol-Myers Squibb made up 0.03% of Mid Continent Capital's portfolio in Q3 2015, its #210 holding.
Mid Continent Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's Bristol-Myers Squibb position peaked at $510K in Q1 2015.
1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.